Literature DB >> 3919054

Blunted prolactin response to thyrotropin-releasing hormone stimulation in cystinotic children receiving cysteamine.

W A Gahl, B B Bercu.   

Abstract

We investigated whether long term cysteamine therapy in cystinotic children altered their basal and stimulated serum PRL levels. Five subjects who had normal plasma PRL responses to TRH stimulation before cysteamine treatment each had a lower basal PRL level and a blunted PRL response during long term (19-59 months) cysteamine therapy. A blunted PRL response was not found in 12 cystinotic subjects of the same age and stage of disease who had not received cysteamine. The effect on PRL release was not found in 2 subjects who received short term (1-2 weeks) treatment with full-dose cysteamine (50 mg/kg . day). The TSH response to TRH stimulation was not blunted during long term cysteamine therapy. These findings suggest that cysteamine alters PRL secretion in humans.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919054     DOI: 10.1210/jcem-60-4-793

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Antithyroid action of carbocisteine.

Authors:  W M Wiersinga
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-12

Review 2.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

3.  Oral cysteamine bitartrate and N-acetylcysteine for patients with infantile neuronal ceroid lipofuscinosis: a pilot study.

Authors:  Sondra W Levin; Eva H Baker; Wadih M Zein; Zhongjian Zhang; Zenaide M N Quezado; Ning Miao; Andrea Gropman; Kurt J Griffin; Simona Bianconi; Goutam Chandra; Omar I Khan; Rafael C Caruso; Aiyi Liu; Anil B Mukherjee
Journal:  Lancet Neurol       Date:  2014-07-02       Impact factor: 44.182

4.  Growth hormone producing prolactinoma in juvenile cystinosis: a simple coincidence?

Authors:  Martine T P Besouw; Elena N Levtchenko; Michèl A A P Willemsen; Kees Noordam
Journal:  Pediatr Nephrol       Date:  2007-07-19       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.